Supplement industry stands together in support of Designer Anabolic Steroid Control Act of 2014
WASHINGTON — A coalition of associations representing supplement manufacturers on Tuesday expressed their support of the Designer Anabolic Steroid Control Act of 2014 by Sens. Sheldon Whitehouse, D-R.I., and Orrin Hatch, R-Utah.
"The trade associations of the dietary supplement industry strongly support DASCA, a bill that protects consumers by empowering the Drug Enforcement Administration with new tools to identify and quickly respond when new designer anabolic steroids — illegal drugs — are falsely marketed as dietary supplements," the coalition stated.
"Among the improvements brought about by DASCA will be new guidelines for DEA to address products that are ‘substantially similar’ to anabolic steroids and that have been illegally marketed to promote muscle growth. In addition, DASCA will place new anabolic steroids on the DEA Controlled Substance List, and will change the criteria for placing additional anabolic steroids on the list going forward," the coalition added. "DASCA will also allow DEA to respond faster to stop those criminals who create new anabolic substances closely resembling listed ones, but tweaked just enough that they are not identical to their flagged counterparts."
The coalition consists of the American Herbal Products Association, the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the Natural Products Association and the United Natural Products Alliance.
Report: Omega-3 supplementation can realize $4 billion in net CHD-attributed cost savings
WASHINGTON — Adults older than 55 years with heart disease would realize individual healthcare savings if they supplemented with omega-3 dietary supplements, according to a report released Tuesday titled "Smart Prevention-Health Care Cost Savings Resulting from the Targeted Use of Dietary Supplements.”
According to the report, nearly $4 billion in cumulative net CHD-attributed cost savings from 2013 to 2020 is potentially realizable if the entire targeted population (U.S. adults older than 55 years diagnosed with CHD) were to use omega-3 dietary supplements at preventive intake levels. This is the equivalent of more than one million hospital events avoided in the next seven years, the report stated. Additionally, the report identified that only 28% of the targeted population currently takes omega-3 supplements.
“Our country is faced with a serious problem when it comes to sick-care and rising healthcare costs,” said Steve Mister, president of the Council for Responsible Nutrition Foundation. “Taking dietary supplements, such as omega-3s, is not a magic bullet by any means, but it’s one preventive measure that should be considered along with eating a healthy diet and exercising regularly to potentially help maintain a healthy heart. Given the costs of treating medical events that result from CHD, simple steps like this can help reduce healthcare costs, too.”
Omega-3s are the third most popular dietary supplement among U.S. adults ages 55 years and older, according to the Council for Responsible Nutrition. The supplement’s essential role in the diet is recognized by such authoritative bodies as the American Heart Association, the World Health Organization, the U.S. Institute of Medicine’s Food and Nutrition Board and the 2010 Dietary Guidelines, all of which have current policies advising Americans to eat more fatty fish to get the benefits of omega-3 fish oils.
“Unfortunately most Americans are not eating enough fatty fish to reap the full benefits of omega-3s,” said Duffy MacKay, SVP scientific and regulatory affairs CRN. “So omega-3 supplementation is a viable option, especially for anyone who doesn’t eat fatty fish, like salmon and sardines, regularly. Omega-3s help lower triglycerides and support healthy blood flow-two factors which play a role in coronary heart disease.”
The report was created by Frost & Sullivan through a grant from the CRNF.
Targeted Medical Pharma to launch Clearwayz supplement through As Seen On TV
LOS ANGELES — Targeted Medical Pharma on Monday reported the completion of a promotion and distribution agreement with As Seen on TV Productions, a division of East Shore Enterprises, to promote the company’s Clearwayz.
Clearwayz is a dietary supplement specially formulated to support healthy sinus, respiratory and immune function using a proprietary blend of amino acids and polyphenols.
"Clearwayz offers a natural, drug-free option to people who are struggling with sinus and respiratory problems related to the cold, flu or allergies and are concerned about the side effects of drugs,” stated William Shell, CEO and chief science officer of Targeted Medical Pharma. “This agreement will introduce this unique product into a broader marketplace, helping to build a sustainable sales channel for the dietary supplement division of the company.”